Novartis receives FDA approval for Rhapsido® , the only oral, targeted BTKi treatment for chronic spontaneous urticaria
Preliminary data of Butembo Copper prospect, with near surface high-grade copper oxidized ore with grades of up to 18%
Forge Resources Intersects Additional Visible Gold in First Hole of Phase II Alotta Drill Program, Yukon
LaFleur Minerals Announces Listing on Tradegate, Bolstering its International Visibility and Exposure to European Markets
